株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

皮膚充填剤:医療機器のパイプライン評価

Dermal Filler - Medical Devices Pipeline Assessment, 2016

発行 GlobalData 商品コード 239483
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.83円で換算しております。
Back to Top
皮膚充填剤:医療機器のパイプライン評価 Dermal Filler - Medical Devices Pipeline Assessment, 2016
出版日: 2016年12月01日 ページ情報: 英文 121 Pages
概要

当レポートでは、世界の皮膚充填剤 (ダーマルフィラー) の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 皮膚充填剤の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 皮膚充填剤:各企業で現在治験中のパイプライン製品

  • 皮膚充填剤の企業:治験段階別のパイプライン製品
  • 皮膚充填剤:治験段階別のパイプライン製品

第5章 皮膚充填剤の企業・製品の概要

  • Aeon Astron Corporation
    • パイプライン製品および進行中の治験の概要
  • Allergan Inc
  • Anika Therapeutics Inc
  • BioPolymer GmbH & Co. KG
  • Cytophil, Inc.
  • Cytosial Biomedic, S.a.s.
  • Dermele Skin Care, LLC
  • EternoGen, LLC
  • FibroGen Inc
  • Galderma SA
  • Innovia LLC
  • Juvenis Ltd.
  • Khorionyx
  • L&C Bio
  • Mentor Worldwide LLC
  • Moma Therapeutics, Inc.
  • Mosaic Medical Technologies, Inc
  • Oligo Medic, Inc.
  • ORGEV Laboratories
  • PetVivo Holdings Inc
  • 積水メディカル
  • Shanghai Haohai Biological Technology Co Ltd
  • Shin Poong PharmCo Ltd
  • Sinclair Pharma PLC
  • Sofregen Medical Inc
  • TEI Biosciences Inc

第6章 皮膚充填剤市場:昨今の動向 (全33件)

第7章 提言

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0284EPD

GlobalData's Medical Devices sector report, "Dermal Filler - Medical Devices Pipeline Assessment, 2016" provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dermal Filler under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dermal Filler under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Dermal Filler Overview 10

3 Products under Development 11

  • 3.1 Dermal Filler - Pipeline Products by Stage of Development 11
  • 3.2 Dermal Filler - Pipeline Products by Territory 12
  • 3.3 Dermal Filler - Pipeline Products by Regulatory Path 13
  • 3.4 Dermal Filler - Pipeline Products by Estimated Approval Date 14
  • 3.5 Dermal Filler - Ongoing Clinical Trials 15

4 Dermal Filler - Pipeline Products under Development by Companies 16

  • 4.1 Dermal Filler Companies - Pipeline Products by Stage of Development 16
  • 4.2 Dermal Filler - Pipeline Products by Stage of Development 18

5 Dermal Filler Companies and Product Overview 20

  • 5.1 Aeon Astron Corporation Company Overview 20
    • 5.1.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 Allergan Inc Company Overview 21
    • 5.2.1 Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Anika Therapeutics Inc Company Overview 26
    • 5.3.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.4 BioPolymer GmbH & Co. KG Company Overview 28
    • 5.4.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.5 Cytophil, Inc. Company Overview 31
    • 5.5.1 Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.6 Cytosial Biomedic, S.a.s. Company Overview 32
    • 5.6.1 Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.7 Dermele Skin Care, LLC Company Overview 34
    • 5.7.1 Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.8 EternoGen, LLC Company Overview 35
    • 5.8.1 EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.9 FibroGen Inc Company Overview 36
    • 5.9.1 FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.10 Galderma SA Company Overview 38
    • 5.10.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.11 Innovia LLC Company Overview 49
    • 5.11.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.12 Juvenis Ltd. Company Overview 50
    • 5.12.1 Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.13 Khorionyx Company Overview 51
    • 5.13.1 Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.14 L&C Bio Company Overview 52
    • 5.14.1 L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.15 Mentor Worldwide LLC Company Overview 53
    • 5.15.1 Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.16 Moma Therapeutics, Inc. Company Overview 55
    • 5.16.1 Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.17 Mosaic Medical Technologies, Inc Company Overview 56
    • 5.17.1 Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 Oligo Medic, Inc. Company Overview 57
    • 5.18.1 Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.19 ORGEV Laboratories Company Overview 58
    • 5.19.1 ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.20 PetVivo Holdings Inc Company Overview 69
    • 5.20.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.21 Sekisui Medical Co Ltd Company Overview 71
    • 5.21.1 Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.22 Shanghai Haohai Biological Technology Co Ltd Company Overview 72
    • 5.22.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.23 Shin Poong PharmCo Ltd Company Overview 75
    • 5.23.1 Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.24 Sinclair Pharma PLC Company Overview 76
    • 5.24.1 Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.25 Sofregen Medical Inc Company Overview 87
    • 5.25.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.26 TEI Biosciences Inc Company Overview 88
    • 5.26.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88

6 Dermal Filler- Recent Developments 89

  • 6.1 Nov 21, 2016: Merz Continues Its Growth in Aesthetics and Neurotoxins 89
  • 6.2 Nov 15, 2016: BTG: Interim results 90
  • 6.3 Nov 08, 2016: FibroGen Reports Financial Results for the Third Quarter of 2016 and Provides Corporate Update 91
  • 6.4 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 91
  • 6.5 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results 93
  • 6.6 Oct 19, 2016: Facial Aesthetics First in Denver to Offer New Treatment to Help Patients Achieve "Goldilocks Lips" 94
  • 6.7 Oct 18, 2016: JUVEDERM VOLBELLA XC Now Available To Doctors And Patients In The U.S. 94
  • 6.8 Oct 10, 2016: Aesthetics Industry Veteran Pat Altavilla Joins Suneva Medical As Vice President Of Marketing 95
  • 6.9 Oct 06, 2016: BTG: close period update 95
  • 6.10 Sep 27, 2016: Orange County Business Council Study Showcases Economic Impact of Allergan on California Economy 96
  • 6.11 Sep 23, 2016: Biologica Technologies launches Allofill injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons 96
  • 6.12 Sep 21, 2016: Sinclair Pharma: Second Interim Statement (Jan-Jun 2016) 97
  • 6.13 Sep 01, 2016: Sinclair Pharma: Restructuring programme and Board change 98
  • 6.14 Aug 08, 2016: FibroGen Reports Financial Results for the Second Quarter of 2016 99
  • 6.15 Aug 04, 2016: Suneva Appoints Preston Romm To Chief Executive Officer And Fortifies Board Of Directors With Industry Leaders 99
  • 6.16 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 100
  • 6.17 Jul 27, 2016: BTG Announces Appointment of Non-executive Director 103
  • 6.18 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results 103
  • 6.19 Jul 18, 2016: Trading update and notification of board changes £17.2m revenue in 1H calendar 2016 104
  • 6.20 Jul 14, 2016: BTG: Annual General Meeting 104
  • 6.21 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 105
  • 6.22 Jun 19, 2016: Body Organ Biomedical to Raise USD5.4 Million in Rights Offering of Shares 105
  • 6.23 Jun 16, 2016: Preston Romm Joins Suneva Medical As Chief Operating Officer 105
  • 6.24 Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 106
  • 6.25 Jun 10, 2016: Galderma Celebrates 20th Global Anniversary of Restylane 107
  • 6.26 Jun 07, 2016: Merz Receives CE Mark for Radiesse (+) Lidocaine 107
  • 6.27 Jun 01, 2016: JUVEDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids 108
  • 6.28 May 17, 2016: BTG: Final Results 109
  • 6.29 May 09, 2016: FibroGen Reports Financial Results for the First Quarter of 2016 113
  • 6.30 Apr 05, 2016: BTG: Close Period Update 114
  • 6.31 Feb 26, 2016: Galderma Delivers Innovation In Dermal Fillers With The Launch Of Restylane Lyft 115
  • 6.32 Jan 21, 2016: RegenScientific launches its CE-marked Renu soft tissue volumizing filler at the International Masters Course on Aging Science (IMCAS) World Congress 2016 116
  • 6.33 Jan 12, 2016: RegenScientific - Cytophil appoints Mr. Ron Renten as Vice President of Sales and Marketing for Aesthetics in Europe, the Middle East, and Africa 116

7 Appendix 118

  • 7.1 Methodology 118
  • 7.2 About GlobalData 121
  • 7.3 Contact Us 121
  • 7.4 Disclaimer 121

List of Tables

1.1 List of Tables

  • Table 1: Dermal Filler - Pipeline Products by Stage of Development 11
  • Table 2: Dermal Filler - Pipeline Products by Territory 12
  • Table 3: Dermal Filler - Pipeline Products by Regulatory Path 13
  • Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14
  • Table 5: Dermal Filler - Ongoing Clinical Trials 15
  • Table 6: Dermal Filler Companies - Pipeline Products by Stage of Development 16
  • Table 7: Dermal Filler - Pipeline Products by Stage of Development 18
  • Table 8: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 9: BioDermal Filler - Product Status 20
  • Table 10: BioDermal Filler - Product Description 20
  • Table 11: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 12: JUVEDERM Volbella - Product Status 21
  • Table 13: JUVEDERM Volbella - Product Description 21
  • Table 14: JUVEDERM VOLIFT - Product Status 22
  • Table 15: JUVEDERM VOLIFT - Product Description 22
  • Table 16: Juvederm VOLUMA XC - Product Status 22
  • Table 17: Juvederm VOLUMA XC - Product Description 23
  • Table 18: Allergan Inc - Ongoing Clinical Trials Overview 23
  • Table 19: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 24
  • Table 20: Juvederm VOLUMA XC - Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVEDERM VOLUMA XC for the Facial Temporal Regions 24
  • Table 21: Juvederm VOLUMA XC - Voluma Treatment of HIV Facial Lipoatrophy 24
  • Table 22: JUVEDERM VOLIFT - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 25
  • Table 23: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 24: Next Generation ELEVESS Dermal Filler - Product Status 26
  • Table 25: Next Generation ELEVESS Dermal Filler - Product Description 27
  • Table 26: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 27: Matridex - Product Status 28
  • Table 28: Matridex - Product Description 29
  • Table 29: Matridur - Product Status 29
  • Table 30: Matridur - Product Description 30
  • Table 31: Matrigel - Product Status 30
  • Table 32: Matrigel - Product Description 30
  • Table 33: Cytophil, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 34: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status 31
  • Table 35: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description 31
  • Table 36: Cytosial Biomedic, S.a.s. Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 37: Chitoderm - Product Status 32
  • Table 38: Chitoderm - Product Description 32
  • Table 39: Cytosmile - Product Status 33
  • Table 40: Cytosmile - Product Description 33
  • Table 41: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 42: Gold Nanoparticle Dermal Filler - Product Status 34
  • Table 43: Gold Nanoparticle Dermal Filler - Product Description 34
  • Table 44: EternoGen, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 45: Collagen Scaffold - Aesthetic Procedures - Product Status 35
  • Table 46: Collagen Scaffold - Aesthetic Procedures - Product Description 35
  • Table 47: FibroGen Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 48: FG-5030 - Product Status 36
  • Table 49: FG-5030 - Product Description 37
  • Table 50: Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 51: Restylane Defyne - Product Status 38
  • Table 52: Restylane Defyne - Product Description 39
  • Table 53: Restylane Lidocaine - Product Status 39
  • Table 54: Restylane Lidocaine - Product Description 39
  • Table 55: Restylane Lyft - Hand Rejuvenation - Product Status 40
  • Table 56: Restylane Lyft - Hand Rejuvenation - Product Description 40
  • Table 57: Restylane Perlane - Product Status 40
  • Table 58: Restylane Perlane - Product Description 41
  • Table 59: Restylane Refyne - Product Status 41
  • Table 60: Restylane Refyne - Product Description 41
  • Table 61: Restylane Skinboosters Vital - Product Status 42
  • Table 62: Restylane Skinboosters Vital - Product Description 42
  • Table 63: Galderma SA - Ongoing Clinical Trials Overview 43
  • Table 64: Restylane Perlane - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population 44
  • Table 65: Restylane Refyne - A Multi-center, Non-comparative Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel Classic Lidocaine and Emervel Deep Lidocaine 45
  • Table 66: Restylane Lidocaine - A Randomized, Multi-center, Subject-blinded and Evaluator-blinded Study Comparing the Pain and the Safety Profile Associated with Correction of Moderate to Severe Nasolabial Folds Using Restylane With and Without Addition of 0.3% Lidocaine Hydrochloride 46
  • Table 67: Restylane Lidocaine - An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population 46
  • Table 68: Restylane Skinboosters Vital - A Randomized, Multi-center, Evaluator-blinded, Split-hand, no Treatment-controlled Study to Evaluate the Safety and Efficacy of Restylane Vital for Skin Rejuvenation of the Dorsal Hands in Chinese Subjects 47
  • Table 69: Restylane Skinboosters Vital - A Randomized, Multi-center, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face 47
  • Table 70: Restylane Defyne - A Multi-center, Non-comparative Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel Classic Lidocaine and Emervel Deep Lidocaine 48
  • Table 71: Restylane Lyft - Hand Rejuvenation - A Randomized, Evaluator Blinded, Split-hand Study to Evaluate the Effectiveness and Safety of Restylane Lyft with Lidocaine Compared to No Treatment for Injection in the Dorsal Hand to Correct Volume Deficit 48
  • Table 72: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 73: Wrinkle Filler - Product Status 49
  • Table 74: Wrinkle Filler - Product Description 49
  • Table 75: Juvenis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 76: Tenergel - Product Status 50
  • Table 77: Tenergel - Product Description 50
  • Table 78: Khorionyx Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 79: Autologous Globin Dermal Filler - Product Status 51
  • Table 80: Autologous Globin Dermal Filler - Product Description 51
  • Table 81: L&C Bio Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 82: Micronized Acellular Dermal Filler - Product Status 52
  • Table 83: Micronized Acellular Dermal Filler - Product Description 52
  • Table 84: Mentor Worldwide LLC Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 85: Prevelle Shape - Product Status 53
  • Table 86: Prevelle Shape - Product Description 53
  • Table 87: Puragen - Product Status 54
  • Table 88: Puragen - Product Description 54
  • Table 89: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 90: Restogel-131 - Product Status 55
  • Table 91: Restogel-131 - Product Description 55
  • Table 92: Mosaic Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 93: Dermal Filler - Product Status 56
  • Table 94: Dermal Filler - Product Description 56
  • Table 95: Oligo Medic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 96: AntaRep - Product Status 57
  • Table 97: AntaRep - Product Description 57
  • Table 98: ORGEV Laboratories Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 99: Macdermol 18 - Product Status 58
  • Table 100: Macdermol 18 - Product Description 59
  • Table 101: Macdermol 21 - Product Status 59
  • Table 102: Macdermol 21 - Product Description 60
  • Table 103: Macdermol 24 - Product Status 60
  • Table 104: Macdermol 24 - Product Description 61
  • Table 105: Macdermol 30 - Product Status 61
  • Table 106: Macdermol 30 - Product Description 62
  • Table 107: Macdermol Bio Lift - Product Status 62
  • Table 108: Macdermol Bio Lift - Product Description 63
  • Table 109: Macdermol Bio Revitalization - Product Status 63
  • Table 110: Macdermol Bio Revitalization - Product Description 64
  • Table 111: Macdermol Hydro - Product Status 64
  • Table 112: Macdermol Hydro - Product Description 65
  • Table 113: Macdermol Lips - Product Status 65
  • Table 114: Macdermol Lips - Product Description 66
  • Table 115: MacDermol R - Product Status 66
  • Table 116: MacDermol R - Product Description 66
  • Table 117: MacDermol S - Product Status 67
  • Table 118: MacDermol S - Product Description 67
  • Table 119: Macdermol Volume - Product Status 67
  • Table 120: Macdermol Volume - Product Description 68
  • Table 121: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 122: Dermal Filler - Product Status 69
  • Table 123: Dermal Filler - Product Description 69
  • Table 124: Dermal Filler - Lip - Product Status 70
  • Table 125: Dermal Filler - Lip - Product Description 70
  • Table 126: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 127: NADGL - Product Status 71
  • Table 128: NADGL - Product Description 71
  • Table 129: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 130: QST Gel - Product Status 72
  • Table 131: QST Gel - Product Description 72
  • Table 132: Second Generation Matrifill - Product Status 73
  • Table 133: Second Generation Matrifill - Product Description 73
  • Table 134: Third Generation Matrifill - Product Status 73
  • Table 135: Third Generation Matrifill - Product Description 74
  • Table 136: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 137: Dermal Filler - Product Status 75
  • Table 138: Dermal Filler - Product Description 75
  • Table 139: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 140: Atlean - Product Status 77
  • Table 141: Atlean - Product Description 77
  • Table 142: Ellanse Hands-M - Product Status 78
  • Table 143: Ellanse Hands-M - Product Description 78
  • Table 144: Ellanse Hands-S - Product Status 79
  • Table 145: Ellanse Hands-S - Product Description 79
  • Table 146: Ellanse Lidocaine - Product Status 80
  • Table 147: Ellanse Lidocaine - Product Description 80
  • Table 148: Ellanse-E - Product Status 81
  • Table 149: Ellanse-E - Product Description 81
  • Table 150: Ellanse-L - Product Status 82
  • Table 151: Ellanse-L - Product Description 82
  • Table 152: Ellanse-M - Product Status 83
  • Table 153: Ellanse-M - Product Description 83
  • Table 154: Ellanse-S - Product Status 84
  • Table 155: Ellanse-S - Product Description 84
  • Table 156: Perfectha G - Product Status 85
  • Table 157: Perfectha G - Product Description 85
  • Table 158: Perfectha Lidocaine - Product Status 85
  • Table 159: Perfectha Lidocaine - Product Description 86
  • Table 160: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 161: Silk Protein - Tissue/Dermal Filler - Product Status 87
  • Table 162: Silk Protein - Tissue/Dermal Filler - Product Description 87
  • Table 163: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 164: Injectable Dermal Filler - Product Status 88
  • Table 165: Injectable Dermal Filler - Product Description 88
  • Table 166: Glossary 119

List of Figures

1.2 List of Figures

  • Figure 1: Dermal Filler - Pipeline Products by Stage of Development 11
  • Figure 2: Dermal Filler - Pipeline Products by Territory 12
  • Figure 3: Dermal Filler - Pipeline Products by Regulatory Path 13
  • Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date 14
  • Figure 5: Dermal Filler - Ongoing Clinical Trials 15
Back to Top